All-cause mortality after major gastrointestinal bleeding among patients receiving direct oral anticoagulants: a protocol for a systematic review and meta-analysis.

BACKGROUND Gastrointestinal (GI) bleeding represents the single most frequent site of anticoagulant-related bleeding. Adverse outcomes after major GI bleeding including mortality are not well characterized and, as a result, may be underappreciated in clinical practice. We aim to conduct a systematic review and meta-analysis of the risk for 30-day all-cause mortality after major GI bleeding among patients receiving DOACs. METHODS Electronic databases including MEDLINE, EMBASE, and Cochrane CENTRAL will be systematically searched to identify randomized controlled trials and prospective and retrospective cohort studies reporting 30-day all-cause mortality in adults with DOAC-related major GI bleeding. At least two investigators will independently perform study selection, risk of bias assessment, and data extraction. The proportion of deaths following a major GI event relative to the number of major GI bleeding events will be calculated for each individual study, and results across studies will be pooled using random-effects meta-analysis. We will assess risk of bias using criteria proposed by the GRADE group for prognostic studies. DISCUSSION The findings of this systematic review and meta-analysis will provide clinicians and patients with estimates of mortality after the most common major bleeding event to support shared decision making about anticoagulation management. TRIAL REGISTRATION PROSPERO CRD42022295815

Destruction of Superconductivity by Impurities in the Attractive Hubbard Model

We study the effect of U=0 impurities on the superconducting and thermodynamic properties of the attractive Hubbard model on a square lattice. Removal of the interaction on a critical fraction of $f_{\rm crit} \approx 0.30$ of the sites results in the destruction of off-diagonal long range order in the ground state. This critical fraction is roughly independent of filling in the range $0.75 < \rho < 1.00$, although our data suggest that $f_{\rm crit}$ might be somewhat larger below half-filling than at $\rho=1$. We also find that the two peak structure in the specific heat is present at $f$ both below and above the value which destroys long range pairing order. It is expected that the high $T$ peak associated with local pair formation should be robust, but apparently local pairing fluctuations are sufficient to generate a low temperature peak

IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.

Follicular lymphoma B cells undergo continuous somatic hypermutation (SHM) of their immunoglobulin variable region genes, generating a heterogeneous tumor population. SHM introduces DNA sequences encoding N-glycosylation sites asparagine-X-serine/threonine (N-gly sites) within the V-region that are rarely found in normal B-cell counterparts. Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with calcium-dependent lectins expressed by tissue macrophages. This novel interaction appears critical for tumor growth and survival. To elucidate the significance of N-gly site presence and loss during ongoing SHM, we tracked site behavior during tumor evolution and progression in a diverse group of patients through next-generation sequencing. A hierarchy of subclones was visualized through lineage trees based on SHM semblance between subclones and their discordance from the germline sequence. We observed conservation of N-gly sites in more than 96% of subclone populations within and across diagnostic, progression, and transformation events. Rare N-gly-negative subclones were lost or negligible from successive events, in contrast to N-gly-positive subclones, which could additionally migrate between anatomical sites. Ongoing SHM of the N-gly sites resulted in subclones with different amino acid compositions across disease events, yet the vast majority of resulting DNA sequences still encoded for an N-gly site. The selection and expansion of only N-gly-positive subclones is evidence of the tumor cells' dependence on sites, despite the changing genomic complexity as the disease progresses. N-gly sites were gained in the earliest identified lymphoma cells, indicating they are an early and stable event of pathogenesis. Targeting the inferred mannose-lectin interaction holds therapeutic promise

“To Live Confidently, Courageously, and Hopefully : Challenging Patriarchy and Sexual Violence at Scripps College

The pervasiveness of sexual violence on college campuses poses a significant problem for students and administrations that seek to promote healthy, safe, and equitable access to higher education. Although federal legislation under Title IX prohibits sexual violence as a form of gender discrimination, cultural climates that promote sexual violence—or rape cultures - continue to inform student experiences on college campuses. This thesis roots the discourse on campus sexual violence in the specific localized context at Scripps College. As a women’s college situated in a small, interconnected consortium of co-ed liberal arts colleges, the case of Scripps College raises critical questions about the ways in which gender and sexism play out on women’s bodies, and influence students’ experiences with embodiment on campus. In this thesis, I present a feminist analysis of the current institutional policies that address sexual violence on campus, in addition to the perspectives of eight student activists currently involved in gender justice work at Scripps College. Due to the fact that each of the Claremont Colleges, including Scripps, is currently in the process of re-evaluating their policies and grievance procedures that address sexual violence on campus, now is a key time to reflect on the past, present, and future of the Claremont Colleges and the role that these institutions play in either deconstructing or reinforcing patriarchal structures of power

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant

Fellowship awarded to S.A) and Bloodwise through funding of the Precision Medicine for Aggressive Lymphoma (PMAL) consortium (1500